SCHEMBL15937360

SCHEMBL15937360

CC1(C)c2cc(-c3ccccc3)ccc2N2c3ccc(-c4ccccc4)cc3C(C)(C)c3cc(-c4ccc(-c5ccc(-c6ccc(-c7cc8c9c(c7)C(C)(C)c7cc(-c%10ccccc%10)ccc7N9c7ccc(-c9ccccc9)cc7C8(C)C)cc6)cc5)cc4)cc1c32

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 5/20 0.33
RARA P10276 1/20 0.33
RARB P10826 1/20 0.33
RARG P13631 1/20 0.33
PDK2 Q15119 1/20 0.33
ALOX5 P09917 1/20 0.32
HSD17B3 P37058 2/20 0.32
LPL P06858 1/20 0.32
LIPG Q9Y5X9 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
TDP2 O95551 1/20 0.31
CTSD P07339 1/20 0.31
BACE1 P56817 1/20 0.31
FAAH O00519 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HSP90AA1 P07900 1/20 0.31
PKM P14618 1/20 0.31
HTT P42858 1/20 0.31
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13353467 1.00 PGR (0.33) PGRRARARARBRARGPDK2
SCHEMBL15937353 1.00 PGR (0.33) PGRRARARARBRARGPDK2
SCHEMBL15937275 1.00 PGR (0.33) PGRRARARARBRARGPDK2
SCHEMBL13353107 1.00 PGR (0.33) PGRRARARARBRARGPDK2
SCHEMBL15937316 1.00 PGR (0.33) PGRRARARARBRARGPDK2
SCHEMBL15937277 0.95 KMT2A (0.34) PGRRARARARBRARGPDK2
SCHEMBL13371089 0.95 KMT2A (0.34) PGRRARARARBRARGPDK2
SCHEMBL15937330 0.95 KMT2A (0.34) PGRRARARARBRARGPDK2
SCHEMBL15937363 0.95 KMT2A (0.34) PGRRARARARBRARGPDK2
SCHEMBL15937351 0.94 PDK2 (0.39) PGRPDK2MEN1KMT2ATDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160126476-A1 NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE LMS CO., LTD. (KR) 2016-05-05 US disclosed
US-20160126476-A1 NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE LMS CO., LTD. (KR) 2016-05-05 US disclosed
WO-2014119895-A1 NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE 주식회사 엘엠에스 (KR) 2014-08-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160126476-A1 NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE ELAVL1, SUN2, PER2 PGR 3029/4885RARA 1705/4885RARB 1937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.